产品详情
简单介绍：
Anti-BARD1抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-BARD1抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-BARD1
Cat. Number:
Anti-BARD1抗体KL-4291R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BRCA1 Associated RING
Anti-BARD1抗体Domain gene 1 (BARD1) interacts with the N terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, BARD1 shares homology with the 2 most conserved regions of BRCA1: the N terminal RING motif and the C terminal BRCT domain. The RING motif is a cysteine rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. The BARD1 protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. BARD1 may be the target of oncogenic mutations in breast or ovarian cancer. BARD1 also plays a role in mediating apoptotic stress and p53 dependent.
Also known as:
BARD-1; Bard1; Bard 1;
Anti-BARD1抗体BARD1_HUMAN; BRCA1 associated RING domain 1; BRCA1 associated RING domain gene 1; BRCA1 associated RING domain protein 1; BRCA1-associated RING domain protein 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BARD1.
●
Predicted Molecular Weight: 85kDa.
Storage:
Shipped at 4℃,
Anti-BARD1抗体Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-BARD1抗体dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-BARD1抗体dilutions must be determined by the end user.
kl782Hu01 碳酸酐酶Ⅱ(CA2)多克隆抗体 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl783Hu01 补体因子P(CFP)多克隆抗体 Polyclonal Antibody to Complement Factor P (CFP)
kl785Hu01 肾损伤分子1(Kim1)多克隆抗体 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Mu01 肾损伤分子1(Kim1)多克隆抗体 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Ra01 肾损伤分子1(Kim1)多克隆抗体 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl786Hu01 纤维胶凝蛋白1(FCN1)多克隆抗体 Polyclonal Antibody to Ficolin 1 (FCN1)
kl786Mu01 纤维胶凝蛋白1(FCN1)多克隆抗体 Polyclonal Antibody to Ficolin 1 (FCN1)
kl788Hu01 细胞程序性死亡蛋白1配体1(PDCD1LG1)多克隆抗体 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl788Mu01 细胞程序性死亡蛋白1配体1(PDCD1LG1)多克隆抗体 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl791Mu01 骨粘连蛋白(ON)多克隆抗体 Polyclonal Antibody to Osteonectin (ON)
kl791Ra01 骨粘连蛋白(ON)多克隆抗体 Polyclonal Antibody to Osteonectin (ON)
kl792Hu01 拓扑异构酶Ⅱ(TOP2)多克隆抗体 Polyclonal Antibody to Topoisomerase II (TOP2)
kl794Hu01 周期素依赖性激酶抑制因子2A(CDKN2A)多克隆抗体 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl794Mu01 周期素依赖性激酶抑制因子2A(CDKN2A)多克隆抗体 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl796Hu01 神经肽S(NPS)多克隆抗体 Polyclonal Antibody to Neuropeptide S (NPS)
kl796Mu01 神经肽S(NPS)多克隆抗体 Polyclonal Antibody to Neuropeptide S (NPS)
kl796Ra01 神经肽S(NPS)多克隆抗体 Polyclonal Antibody to Neuropeptide S (NPS)
kl797Hu01 血管紧张素原(AGT)多克隆抗体 Polyclonal Antibody to Angiotensinogen (AGT)
kl797Mu01 血管紧张素原(AGT)多克隆抗体 Polyclonal Antibody to Angiotensinogen (AGT)
